Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN)

Q: What does CUSIP 25056L103 represent in this 13F holders report?

CUSIP 25056L103 is the security identifier for DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q2 2021?

49 institutional investors reported DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 25056L103

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 61,880,773
Total 13F shares: 27,817,792
Share change: +2,076,161
Total reported value: $545,865,000
Price per share: $19.89
Number of holders: 49
Value change: +$37,059,194
Number of buys: 31
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 25056L103?
CUSIP 25056L103 identifies DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 25056L103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Cormorant Asset Management, LP	13F	Company	8.3%	5,114,850	$146,409,000	—	31 Mar 2021	13F
Logos Global Management LP	13F	Company	4.4%	2,732,501	$81,702,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	4.1%	2,534,703	$75,788,000	—	31 Mar 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.5%	2,186,636	$65,380,000	—	31 Mar 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	2.3%	1,436,636	$42,955,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.3%	1,435,254	$41,934,000	—	31 Mar 2021	13F
Avoro Capital Advisors LLC	13F	Company	2.4%	1,468,318	$39,702,000	—	31 Mar 2021	13F
EcoR1 Capital, LLC	13F	Company	1.8%	1,137,940	$34,024,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.8%	1,141,985	$33,478,000	—	31 Mar 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.9%	1,186,636	$32,704,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	1.6%	1,000,000	$29,900,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	1.3%	791,019	$23,652,000	—	31 Mar 2021	13F
Vivo Capital, LLC	13F	Company	0.86%	530,991	$15,877,000	—	31 Mar 2021	13F
Artal Group S.A.	13F	Company	0.65%	400,000	$11,960,000	—	31 Mar 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.65%	400,000	$11,960,000	—	31 Mar 2021	13F
Rock Springs Capital Management LP	13F	Company	0.53%	327,250	$9,785,000	—	31 Mar 2021	13F
HHLR ADVISORS, LTD.	13F	Company	0.45%	280,991	$8,402,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.41%	253,037	$7,566,000	—	31 Mar 2021	13F
Octagon Capital Advisors LP	13F	Company	0.4%	250,000	$7,475,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.32%	200,000	$5,980,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.32%	200,000	$5,980,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	0.2%	124,991	$3,738,000	—	31 Mar 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.17%	107,408	$3,212,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.13%	83,450	$2,495,000	—	31 Mar 2021	13F
CREDIT SUISSE AG/	13F	Company	0.1%	61,428	$1,837,000	—	31 Mar 2021	13F
Legal & General Group Plc	13F	Company	0.1%	60,500	$1,830,000	—	31 Mar 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.08%	50,000	$1,495,000	—	31 Mar 2021	13F
Ensign Peak Advisors, Inc	13F	Company	0.08%	50,000	$1,495,000	—	31 Mar 2021	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.07%	43,250	$1,293,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	37,700	$1,127,000	—	31 Mar 2021	13F
OLD MISSION CAPITAL LLC	13F	Company	0.04%	26,700	$798,000	—	31 Mar 2021	13F
Squarepoint Ops LLC	13F	Company	0.04%	23,493	$702,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	21,621	$646,000	—	31 Mar 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.03%	21,322	$638,000	—	31 Mar 2021	13F
Alpine Global Management, LLC	13F	Company	0.02%	13,405	$401,000	—	31 Mar 2021	13F
Maven Securities LTD	13F	Company	0.02%	10,000	$299,000	—	31 Mar 2021	13F
Point72 Hong Kong Ltd	13F	Company	0.01%	8,304	$248,000	—	31 Mar 2021	13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY	13F	Company	0.01%	8,300	$248,000	—	31 Mar 2021	13F
Spire Wealth Management	13F	Company	0%	900	$27,000	—	31 Mar 2021	13F
FIRST MERCANTILE TRUST CO	13F	Company	0%	700	$21,000	—	31 Mar 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	398	$12,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0%	300	$9,000	—	31 Mar 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	36	$1,000	—	31 Mar 2021	13F

Institutional Holders of Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN) as of Q2 2021

As of 30 Jun 2021, Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,817,792 shares. The largest 10 holders included Cormorant Asset Management, LP, Logos Global Management LP, CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, BlackRock Inc., EcoR1 Capital, LLC, and VANGUARD GROUP INC. This page lists 49 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.